Nonetheless, IKKα’s role in KRAS-induced lung cancer remains controversial, as a second report claims that IKKα acts as a tumour suppressor and that IKKα genetic deletion actually promotes KRAS-induced lung cancer [59]. The gene discussed is KRAS; the disease is lung cancer.